Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary

John P. Geisler, Robert Goulet, Richard S. Foster, Gregory P. Sutton

Research output: Contribution to journalArticle

35 Scopus citations


Background: The growing teratoma syndrome has been described with regard to gonadal and extragonadal germ cell neoplasms in males, but few cases have been reported in the female population. In this condition, masses that enlarge during or after chemotherapy are found to contain mature teratoma without malignant elements. Cases: Three patients had either persistent or growing masses despite chemotherapy for germ cell malignancies of the ovary. All cases fit the description of the growing teratoma syndrome. The patients were aged 20–22 years. All three patients had immature teratomas before chemotherapy. The stages of disease ranged from la to IIIc. All patients had normal tumor markers while their masses showed growth or persistence. All were free of disease 6–31 months after diagnosis. Conclusion: Growth or persistence of a tumor after chemotherapy for malignant teratoma does not necessarily imply progression of malignancy, especially if tumor markers are normal. However, these masses should be resected because they may cause obstruction, compression, or displacement of adjacent organs, or undergo sarcomatous degeneration. (Ob-stet Gynecol 1994;84:719–21).

Original languageEnglish (US)
Pages (from-to)719-721
Number of pages3
JournalObstetrics and gynecology
Issue number4
StatePublished - Oct 1994

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary'. Together they form a unique fingerprint.

  • Cite this